Combination therapy adding tadalafil to existing ambrisentan in patients with pulmonary arterial hypertension

被引：3
|
作者：
Hirashiki, Akihiro [1 ]
Kondo, Takahisa [1 ]
Murohara, Toyoaki [2 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Adv Med Cardiopulmonary Dis, Nagoya, Aichi 4648601, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan
来源：
HYPERTENSION RESEARCH | 2014年 / 37卷 / 06期
关键词：
METAANALYSIS; BOSENTAN;
D O I：
10.1038/hr.2014.37
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：488 / 489
页数：2
相关论文
共 50 条
  • [1] Combination therapy adding tadalafil to existing ambrisentan in patients with pulmonary arterial hypertension
    Akihiro Hirashiki
    Takahisa Kondo
    Toyoaki Murohara
    [J]. Hypertension Research, 2014, 37 : 488 - 489
  • [2] Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension
    Zhuang, Yugang
    Jiang, Bojie
    Gao, Hui
    Zhao, Wei
    [J]. HYPERTENSION RESEARCH, 2014, 37 (06) : 507 - 512
  • [3] Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension
    Yugang Zhuang
    Bojie Jiang
    Hui Gao
    Wei Zhao
    [J]. Hypertension Research, 2014, 37 : 507 - 512
  • [4] EFFECTIVENESS AND SAFETY OF COMBINATION THERAPY WITH AMBRISENTAN AND TADALAFIL FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN CHILDREN
    Issapour, Azadeh
    Crook, Sarah
    Hite, Michelle
    Rosenzweig, Erika Berman
    Frank, Benjamin
    Ivy, Dunbar
    Krishnan, Usha
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2086 - 2086
  • [5] Upfront triple combination therapy with ambrisentan, tadalafil and subcutaneous treprostinil in incident patients with severe pulmonary arterial hypertension
    D'Alto, M.
    Romeo, E.
    Argiento, P.
    Badagliacca, R.
    Papa, S.
    Farro, A.
    Sarubbi, B.
    Russo, M. G.
    Vizza, C. D.
    Golino, P.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 3037 - 3037
  • [6] Ambrisentan (Letairis) and Tadalafil (Adcirca) for Pulmonary Arterial Hypertension
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1485): : 2 - 4
  • [7] Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
    Hassoun, Paul M.
    Zamanian, Roham T.
    Damico, Rachel
    Lechtzin, Noah
    Khair, Rubina
    Kolb, Todd M.
    Tedford, Ryan J.
    Hulme, Olivia L.
    Housten, Traci
    Pisanello, Chiara
    Sato, Takahiro
    Pullins, Erica H.
    Corona-Villalobos, Celia P.
    Zimmerman, Stefan L.
    Gashouta, Mohamed A.
    Minai, Omar A.
    Torres, Fernando
    Girgis, Reda E.
    Chin, Kelly
    Mathai, Stephen C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (09) : 1102 - 1110
  • [8] Efficacy Between Combination of Ambrisentan and Tadalafil versus Monotherapy in Patients with Pulmonary Arterial Hypertension: Systematic Review
    Zebua, Alfred
    Sabran, Mohammad Z.
    Nathania, F.
    Harjanto, Jovanda A.
    Rubismo, Kenza Y.
    Kurniawan, Andree
    [J]. JOURNAL OF HYPERTENSION, 2024, 42 (SUPPL 2)
  • [9] Initial combination therapy with ambrisentan plus tadalafil on pulmonary arterial hypertension-related hospitalization in the AMBITION trial
    Vachiery, Jean-Luc
    Galie, Nazzareno
    Barbera, Joan Albert
    Frost, Adaani E.
    Ghofrani, Hossein-Ardeschir
    Hoeper, Marius M.
    McLaughlin, Vallerie V.
    Peacock, Andrew J.
    Simonneau, Gerald
    Blair, Christiana
    Miller, Karen L.
    Langley, Jonathan
    Rubin, Lewis J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (02): : 194 - 202
  • [10] Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
    Galie, N.
    Barbera, J. A.
    Frost, A. E.
    Ghofrani, H-A.
    Hoeper, M. M.
    McLaughlin, V. V.
    Peacock, A. J.
    Simonneau, G.
    Vachiery, J-L.
    Gruenig, E.
    Oudiz, R. J.
    Vonk-Noordegraaf, A.
    White, R. J.
    Blair, C.
    Gillies, H.
    Miller, K. L.
    Harris, J. H. N.
    Langley, J.
    Rubin, L. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (09): : 834 - 844
12345